OC-514
N/A
Report date: 2025/04/03 11:03:59
NME
Base Information
Drug NameOC-514
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsYes
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOncocross Australia Pty Ltd
China Registration ClassN/A
Develop Information
Active CompaniesOncocross Co LtdOncocross Australia Pty Ltd
Inactive CompaniesN/A
Active Indications +[5]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A